- Home
- TASK vs BCRX Comparison
TASK vs BCRX Comparison
Compare TASK & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TASK
- BCRX
- Stock Information
- Founded
- TASK 2008
- BCRX 1986
- Country
- TASK United States
- BCRX United States
- Employees
- TASK N/A
- BCRX N/A
- Industry
- TASK Retail: Computer Software & Peripheral Equipment
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TASK Technology
- BCRX Health Care
- Exchange
- TASK Nasdaq
- BCRX Nasdaq
- Market Cap
- TASK 1.5B
- BCRX 1.8B
- IPO Year
- TASK 2021
- BCRX 1994
- Fundamental
- Price
- TASK $14.61
- BCRX $7.31
- Analyst Decision
- TASK Buy
- BCRX Strong Buy
- Analyst Count
- TASK 4
- BCRX 10
- Target Price
- TASK $16.88
- BCRX $16.70
- AVG Volume (30 Days)
- TASK 540.1K
- BCRX 3.1M
- Earning Date
- TASK 11-06-2025
- BCRX 11-03-2025
- Dividend Yield
- TASK N/A
- BCRX N/A
- EPS Growth
- TASK 21.25
- BCRX N/A
- EPS
- TASK 0.67
- BCRX N/A
- Revenue
- TASK $1,101,465,000.00
- BCRX $557,506,000.00
- Revenue This Year
- TASK $19.10
- BCRX $41.40
- Revenue Next Year
- TASK $11.73
- BCRX $5.33
- P/E Ratio
- TASK $22.31
- BCRX N/A
- Revenue Growth
- TASK 19.04
- BCRX 45.85
- 52 Week Low
- TASK $10.57
- BCRX $6.02
- 52 Week High
- TASK $19.60
- BCRX $11.31
- Technical
- Relative Strength Index (RSI)
- TASK 14.87
- BCRX 39.51
- Support Level
- TASK $16.78
- BCRX $7.24
- Resistance Level
- TASK $17.94
- BCRX $7.47
- Average True Range (ATR)
- TASK 0.43
- BCRX 0.20
- MACD
- TASK -0.33
- BCRX -0.02
- Stochastic Oscillator
- TASK 6.38
- BCRX 37.88
About TASK TaskUs Inc.
TaskUs Inc is a provider of outsourced digital services and next-generation customer experience to the world-wide Game-changing companies, helping its clients represent, protect and grow their brands. It serves clients in the fastest-growing sectors, including social media, e-commerce, gaming, streaming media, food delivery and ridesharing, HiTech, FinTech and HealthTech.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.